IncFact
Company Profiles: Revenue, Growth, Competition

Ocular Therapeutix Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Ocular Therapeutix

Access the complete profile.

Ocular Therapeutix Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
339115 Ophthalmic Goods Manufacturing
Address24 Crosby Dr
Bedford, MA 01730

Note: Revenues for privately held companies are statistical evaluations.


Ocular Therapeutix's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Ocular Therapeutix is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Ocular Therapeutix Annual Revenue and Growth Rate

Ocular Therapeutix Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Ocular Therapeutix's revenues are gauged from an analysis of company filings.



Ocular Therapeutix's Income Statement (based on Industry Averages)

Ocular Therapeutix P&L$ Millions
Revenue (Sales) Ocular Therapeutix Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Ocular Therapeutix is developing and marketing. Ocular Therapeutix's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
AXTOKI
Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions
03/27/2023
EXTENLY
Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions
03/27/2023
AXPAXTLI
Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Intravitreal implants containing drug delivery inserts sold filled with pharmaceutical preparations for the treatment of vision diseases, disorders and conditions; Pharmaceutical preparations for the treatment of eye diseases, disorders and conditions; Pharmaceutical preparations for the treatment of vision diseases, disorders and conditions
03/27/2023

See all trademarks and details in the Full Report.


Market Share of Ocular Therapeutix's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ocular Therapeutix, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Ocular Therapeutix. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
IROBOTBedford, MA100 
LFB USAFramingham, MA16 
OCULAR THERAPEUTIXBedford, MA15 
HOMOLOGY MEDICINEBedford, MA11 
AVANIA US GROUPMarlborough, MA10 
Q-PEAKBedford, MA10 




Future Competition: Ocular Therapeutix's Fastest Growing Competitors

These companies are in the same general field as Ocular Therapeutix and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Ocular Therapeutix Competitors